Literature DB >> 9206801

Distribution of prostaglandin E receptors in the rat gastrointestinal tract.

M Ding1, Y Kinoshita, K Kishi, H Nakata, S Hassan, C Kawanami, Y Sugimoto, M Katsuyama, M Negishi, S Narumiya, A Ichikawa, T Chiba.   

Abstract

AIMS: In order to study the role of prostaglandin in the regulation of the gastrointestinal functions, gene expression of prostaglandin receptors along the rat gastrointestinal tracts were investigated.
METHODS: Rats were used for the study. The combination of counterflow elutriation separation of mucosal cells and Northern blot analysis was used to detect the gene expression of prostaglandin receptors in gastrointestinal tracts.
RESULTS: In small intestine and colon, prostaglandin E2 EP1 and EP3 receptor mRNAs were mainly localized in the deeper intestinal wall containing muscle layers. EP4 receptor gene expression, on the other hand, was detected in the intestinal mucosal layer. In the stomach, EP1 mRNA was detected in gastric muscle layers, whereas EP3 and EP4 receptor gene expression was mainly present in the gastric mucosal layer containing epithelial cells. In gastric epithelial cells, parietal cells were found to have both EP3 and EP4 receptors. At lower concentrations, prostaglandin E2 inhibited gastric acid secretion by parietal cells probably through EP4 receptors. At higher concentrations, however, it stimulated it. On the other hand, mucous cells possessed only EP4 receptor mRNA.
CONCLUSIONS: Thus, it is suggested that prostaglandin E2 modulates gastrointestinal functions through at least three different prostaglandin receptors (EP1, EP3, and EP4), each of which has a distinct contribution in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9206801     DOI: 10.1016/s0090-6980(97)00015-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  15 in total

1.  Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.

Authors:  Liying Dai; Denis W King; D Shevy Perera; David Z Lubowski; Elizabeth Burcher; Lu Liu
Journal:  Dig Dis Sci       Date:  2015-02-11       Impact factor: 3.199

Review 2.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

Review 3.  Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility.

Authors:  Koji Takeuchi
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

4.  Attenuation of stress-induced gastric lesions by lansoprazole, PD-136450 and ranitidine in rats.

Authors:  S I Chandranath; S M A Bastaki; A D'Souza; A Adem; J Singh
Journal:  Mol Cell Biochem       Date:  2010-11-30       Impact factor: 3.396

5.  Acute increase, stimulated by prostaglandin E2, in glucose absorption via the sodium dependent glucose transporter-1 in rat intestine.

Authors:  B Scholtka; F Stümpel; K Jungermann
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

6.  Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors.

Authors:  Y Okada; A Hara; H Ma; C Y Xiao; O Takahata; Y Kohgo; S Narumiya; F Ushikubi
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin.

Authors:  Yongmin Kim; Satoko Yokoyama; Jiro Watari; Kazutoshi Hori; Takahisa Yamasaki; Takuya Okugawa; Fumihiko Toyoshima; Takashi Kondo; Jun Sakurai; Junji Tanaka; Toshihiko Tomita; Tadayuki Oshima; Hirokazu Fukui; Takashi Abe; Takayuki Matsumoto; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2012-02-18       Impact factor: 7.527

8.  Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.

Authors:  Y Shoji; M Takahashi; T Kitamura; K Watanabe; T Kawamori; T Maruyama; Y Sugimoto; M Negishi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

9.  EP4 agonist alleviates indomethacin-induced gastric lesions and promotes chronic gastric ulcer healing.

Authors:  Guang-Liang Jiang; Wha-Bin Im; Yariv Donde; Larry-A Wheeler
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

10.  Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.

Authors:  Henri Duboc; Ganna Tolstanova; Pu-Qing Yuan; Vincent Wu; Izumi Kaji; Mandy Biraud; Yasutada Akiba; Jonathan Kaunitz; Mulugeta Million; Yvette Tache; Muriel Larauche
Journal:  Neurogastroenterol Motil       Date:  2016-06-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.